1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

$Thumbnail for A Normally Composed but Functionally Silenced NK Cell Compartment Defines Double-Refractory Chronic Lymphocytic Leukemia and Rationalizes NK-Engaging Therapies$

CLL - 1489

A Normally Composed but Functionally Silenced NK Cell Compartment Defines Double-Refractory Chronic Lymphocytic Leukemia and Rationalizes NK-Engaging Therapies

Richard I Lewis

Poster Presenter: Richard I Lewis

CML - 1215

A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia

Rahul Kumar Thakur

Poster Presenter: Rahul Kumar Thakur

Thumbnail for A Phase 1/2, First-in-Human, Multicenter Study of DS3790, a CD37-Directed DXd Antibody-Drug Conjugate, in Patients With B-Cell Non-Hodgkin Lymphoma

ABCL - 753

A Phase 1/2, First-in-Human, Multicenter Study of DS3790, a CD37-Directed DXd Antibody-Drug Conjugate, in Patients With B-Cell Non-Hodgkin Lymphoma

Jin Jin

Poster Presenter: Jin Jin

Thumbnail for A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's-Choice Thrombopoietin Receptor Agonist in Patients With Primary Immune Thrombocytopenia: VAY2EXPLORE Study Design

MDS - 1074

A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's-Choice Thrombopoietin Receptor Agonist in Patients With Primary Immune Thrombocytopenia: VAY2EXPLORE Study Design

Mary Lisha Paul

Poster Presenter: Mary Lisha Paul

Thumbnail for A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

MPN - 973

A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

Thumbnail for A phase I dose-finding study of mogamulizumab in combination with brentuximab vedotin in previously treated mycosis fungoides and Sιzary syndrome

TCL - 727

A phase I dose-finding study of mogamulizumab in combination with brentuximab vedotin in previously treated mycosis fungoides and Sιzary syndrome

Lauren Shea

Poster Presenter: Lauren Shea

$Thumbnail for A phase I/II study of gilteritinib and momelotinib in adults with relapsed or refractory FLT3-mutated acute myeloid leukemia$

AML - 1687

A phase I/II study of gilteritinib and momelotinib in adults with relapsed or refractory FLT3-mutated acute myeloid leukemia

Nicholas Short

Poster Presenter: Nicholas Short

Thumbnail for A Prospective Study on Frequency of Anemia in Children Diagnosed With Acute Leukemia vs Solid Tumors and Response to Therapy: A Single-Center Experience in Egypt

ALL - 197

A Prospective Study on Frequency of Anemia in Children Diagnosed With Acute Leukemia vs Solid Tumors and Response to Therapy: A Single-Center Experience in Egypt

Amira Adly

Poster Presenter: Amira Adly

MM - 1347

A Quarter century of Multiple Myeloma Mortality: Evolving Trends in Older Americans from a Nationwide CDC WONDER Analysis

Moazzam Hussain

Poster Presenter: Moazzam Hussain